Zeke Capital Advisors’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $19.3K | Hold |
3,567
| – | – | ﹤0.01% | 469 |
|
|
2022
Q3 | $31K | Hold |
3,567
| – | – | ﹤0.01% | 464 |
|
|
2022
Q2 | $45K | Hold |
3,567
| – | – | ﹤0.01% | 476 |
|
|
2022
Q1 | $91K | Buy |
3,567
+1,670
| +88% | +$42.6K | ﹤0.01% | 505 |
|
|
2021
Q4 | $87K | Hold |
1,897
| – | – | 0.01% | 308 |
|
|
2021
Q3 | $175K | Buy |
1,897
+1,334
| +237% | +$123K | 0.01% | 283 |
|
|
2021
Q2 | $81K | Sell |
563
-1,004
| -64% | -$144K | 0.01% | 315 |
|
|
2021
Q1 | $442K | Sell |
1,567
-46
| -3% | -$13K | 0.03% | 144 |
|
|
2020
Q4 | $410K | Buy |
+1,613
| New | +$410K | 0.03% | 142 |
|